Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Breast Cancer Research : BCR|April 1, 2025
CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistanceBarbara A Lipert, Kyla N Siemens, Aziza Khan, et al.
Dalton Transactions (Cambridge, England : 2003)|November 5, 2025
Platinum(II) complexes of fluorinated pyrrole carbothioamides: enhanced anticancer activity and overcoming cisplatin resistanceHaiming Tang, Chen Chen, Yuhang Fu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 15, 2020
Influenza increases invasive meningococcal disease risk in temperate countriesA Salomon, I Berry, A R Tuite, et al.
Inorganic Chemistry|September 16, 2021
Anthracenyl Functionalization of Half-Sandwich Carbene Complexes: In Vitro Anticancer Activity and Reactions with BiomoleculesBetty Y T Lee, Matthew P Sullivan, Ena Yano, et al.
Biomedicines|January 30, 2021
High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium ComplexesMd Salman Shakil, Shahida Parveen, Zohaib Rana, et al.
Chemmedchem|July 1, 2021
Triazolyl-Functionalized N-Heterocyclic Carbene Half-Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer ActivityKelvin K H Tong, Muhammad Hanif, Sanam Movassaghi, et al.
Bioorganic & Medicinal Chemistry|January 14, 2014
Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)Jack U Flanagan, Graham J Atwell, Daniel M Heinrich, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 7, 2014
Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmatesI S Schwartz, P J Bach, B Roscoe, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 10, 2024
Masking the Bioactivity of Hydroxamic Acids by Coordination to Cobalt: Towards Bioreductive Anticancer AgentsDavid M Goodman, Cornelia U Ritter, Erin Chen, et al.
Journal of Medicinal Chemistry|July 15, 2024
Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as RadiosensitizersCho R Hong, Lydia P Liew, Way W Wong, et al.
Pageof 12